|
CLCN5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.94011473553246E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.26899951552662E-10 |
| Normal-vs-Stage2 |
1.10070000003404E-06 |
| Normal-vs-Stage3 |
3.70530000015634E-07 |
| Normal-vs-Stage4 |
2.21919999999765E-05 |
| Stage1-vs-Stage2 |
7.466400E-01 |
| Stage1-vs-Stage3 |
5.404800E-01 |
| Stage1-vs-Stage4 |
2.613000E-01 |
| Stage2-vs-Stage3 |
8.377200E-01 |
| Stage2-vs-Stage4 |
3.361200E-01 |
| Stage3-vs-Stage4 |
5.015000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.51674245280265E-12 |
| Normal-vs-AfricanAmerican |
8.68499999695516E-08 |
| Normal-vs-Asian |
2.642400E-03 |
| Caucasian-vs-AfricanAmerican |
6.745600E-01 |
| Caucasian-vs-Asian |
7.574200E-01 |
| AfricanAmerican-vs-Asian |
6.798600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.51329999642513E-08 |
| Normal-vs-Female |
1.39939999999061E-06 |
| Male-vs-Female |
4.954000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.19910000104551E-08 |
| Normal-vs-Extreme_Weight |
4.73829997460484E-09 |
| Normal-vs-Obese |
2.51569998166445E-09 |
| Normal-vs-Extreme_Obese |
1.269550E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.959600E-01 |
| Normal_Weight-vs-Obese |
5.049400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.276440E-01 |
| Extreme_Weight-vs-Obese |
3.585800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.628100E-02 |
| Obese-vs-Extreme_Obese |
1.631840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.56109997046161E-09 |
| Normal-vs-Age(41-60Yrs) |
2.44869999832531E-08 |
| Normal-vs-Age(61-80Yrs) |
8.39328606616618E-14 |
| Normal-vs-Age(81-100Yrs) |
1.560640E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.164800E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.895000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.242620E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.462370E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.073200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.150400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.58102436592844E-12 |
| Normal-VS-Type2 PRCC |
1.89089999991232E-07 |
| Normal-VS-KIRP CIMP |
1.66078262253677E-12 |
| Normal-VS-Unclassified PRCC |
2.08199999995884E-06 |
| Type1 PRCC-VS-Type2 PRCC |
6.803800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.7025050520233E-11 |
| Type1 PRCC-VS-Unclassified PRCC |
7.386000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.96959998205659E-09 |
| Type2 PRCC-VS-Unclassified PRCC |
9.707400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.30549999999285E-06 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.78319997341015E-09 |
| Normal-vs-N1 |
2.80840000033145E-07 |
| Normal-vs-N2 |
1.219820E-03 |
| N0-vs-N1 |
5.437600E-01 |
| N0-vs-N2 |
2.525000E-01 |
| N1-vs-N2 |
5.300200E-01 |
|
|
